Gallate J E, Saharov T, Mallet P E, McGregor I S
Department of Psychology, University of Sydney, NSW, Australia.
Eur J Pharmacol. 1999 Apr 16;370(3):233-40. doi: 10.1016/s0014-2999(99)00170-3.
A series of experiments examined the effects of the cannabinoid CB1 receptor agonist CP 55,940 ((-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hyd roxypropyl)cyclohexanol) on the motivation to consume beer, near-beer (a beer-like beverage containing <0.5% ethanol) and sucrose solutions in rats. The experiments employed a 'lick-based progressive ratio paradigm' in which an ever increasing number of licks had to be emitted at a tube for each successive fixed unit of beverage delivered. Break point, the lick requirement at which responding ceased, was used as an index of motivation. In the first experiment, CP 55,940 (10, 30 or 50 microg/kg) caused a dose-dependent increase in break points for beer (containing 4.5% ethanol v/v) and for near-beer. The highest (50 microg/kg) dose of CP 55,940 also significantly decreased locomotor activity. In the second experiment, CP 55,940 (10 or 30 microg/kg) dose-dependently increased break points in rats licking for 'light' beer (containing 2.7% ethanol v/v) or for a sucrose solution (8.6% w/v) containing the same number of calories as the beer. In the third experiment, the facilitatory effects of CP 55,940 (30 microg/kg) on responding for beer and near-beer were reversed by both the cannabinoid CB1 receptor antagonist SR 141716 (N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-me thyl-1H-pyrazole-3-carboxamide hydrochloride) (1.5 mg/kg) and the opioid receptor antagonist naloxone (2.5 mg/kg). Naloxone had a proportionally greater effect on rats licking for beer compared to near-beer, consistent with previous reports of opioid receptor mediation of alcohol craving. These results show that cannabinoids modulate the motivation for beer via both cannabinoid CB1 receptors and opioid receptors. The similar effect of CP 55,940 on the motivation for beer, near-beer and sucrose suggests that the drug effect may reflect a general stimulatory effect on appetite for palatable beverages, although a more specific effect on the desire for alcohol cannot be ruled out.
一系列实验研究了大麻素CB1受体激动剂CP 55,940((-)-顺式-3-[2-羟基-4-(1,1-二甲基庚基)苯基]-反式-4-(3-羟丙基)环己醇)对大鼠饮用啤酒、淡啤酒(一种含乙醇<0.5%的类似啤酒的饮料)和蔗糖溶液的动机的影响。实验采用了“基于舔舐的渐进比率范式”,即每递送一个固定单位的饮料,在一根管子上需要发出的舔舐次数不断增加。断点,即反应停止时的舔舐要求,被用作动机指标。在第一个实验中,CP 55,940(10、30或50微克/千克)导致啤酒(含4.5%乙醇v/v)和淡啤酒的断点呈剂量依赖性增加。CP 55,940的最高剂量(50微克/千克)也显著降低了运动活性。在第二个实验中,CP 55,940(10或30微克/千克)剂量依赖性地增加了舔舐“低度”啤酒(含2.7%乙醇v/v)或含与啤酒相同卡路里数的蔗糖溶液(8.6% w/v)的大鼠的断点。在第三个实验中,大麻素CB1受体拮抗剂SR 141716(N-(哌啶-1-基)-5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基-1H-吡唑-3-甲酰胺盐酸盐)(1.5毫克/千克)和阿片受体拮抗剂纳洛酮(2.5毫克/千克)均可逆转CP 55,940(30微克/千克)对啤酒和淡啤酒反应的促进作用。与淡啤酒相比,纳洛酮对舔舐啤酒的大鼠的作用比例更大,这与先前关于阿片受体介导酒精渴望的报道一致。这些结果表明,大麻素通过大麻素CB1受体和阿片受体调节对啤酒的动机。CP 55,940对啤酒、淡啤酒和蔗糖动机的类似作用表明,该药物作用可能反映了对美味饮料食欲的一般刺激作用,尽管不能排除对酒精渴望的更特异性作用。